AAAAAA
Results: 1-25/227
Authors:
JONES A
HARRIS AL
Citation: A. Jones et Al. Harris, NEW DEVELOPMENTS IN ANGIOGENESIS - A MAJOR MECHANISM FOR TUMOR-GROWTHAND TARGET FOR THERAPY, The cancer journal from Scientific American, 4(4), 1998, pp. 209-217
Authors:
OBYRNE KJ
HAN C
MITCHELL K
LANE D
CARMICHAEL J
HARRIS AL
TALBOT DC
Citation: Kj. Obyrne et al., PHASE-II STUDY OF LIAROZOLE IN ADVANCED NONSMALL CELL LUNG-CANCER, European journal of cancer, 34(9), 1998, pp. 1463-1466
Authors:
KAKOLYRIS S
GIATROMANOLAKI A
KOUKOURAKIS MI
GEORGOULIAS V
GATTER KC
HARRIS AL
Citation: S. Kakolyris et al., HUMAN AP ENDONUCLEASE-1 (HAP1) NUCLEAR EXPRESSION CORRELATES WITH SURVIVAL IN OPERABLE NONSMALL CELL LUNG-CANCER, European journal of cancer, 34, 1998, pp. 133-133
Authors:
HARRIS AL
Citation: Al. Harris, ANTI ANGIOGENESIS THERAPY AND STRATEGIES, European journal of cancer, 34, 1998, pp. 33-33
Authors:
WINTERS ZE
ONGKEKO WM
HARRIS AL
NORBURY CJ
Citation: Ze. Winters et al., P53 REGULATES CDC2 INDEPENDENTLY OF INHIBITORY PHOSPHORYLATION TO REINFORCE RADIATION-INDUCED G2 ARREST IN HUMAN-CELLS, Oncogene, 17(6), 1998, pp. 673-684
Authors:
HARRIS AL
Citation: Al. Harris, PHASE-I DESIGN WITH NEW TARGETS - DO WE NEED NEW DESIGNS FOR PHASE-I TRIALS, Annals of oncology, 9, 1998, pp. 19-19
Authors:
HARRIS AL
Citation: Al. Harris, METALLOPROTEASE INHIBITORS, Annals of oncology, 9, 1998, pp. 33-33
Authors:
PROPPER D
MCDONALD A
THAVASU P
BALKWILL F
CAPONIGRO F
YAP A
CHAMPAIN K
CSERMAK K
TALBOT D
KAYE S
HARRIS AL
TWELVES C
Citation: D. Propper et al., PHASE-I STUDY OF THE PROTEIN-KINASE-C INHIBITOR CGP-41251 - TOLERABILITY AND EFFECTS ON SIGNAL-TRANSDUCTION EX-VIVO, Annals of oncology, 9, 1998, pp. 428-428
Authors:
CHAO D
BAHL P
HOULBROOK S
HOY L
HARRIS AL
AUSTYN JM
Citation: D. Chao et al., HUMAN CULTURED DENDRITIC CELLS SHOW DIFFERENTIAL SENSITIVITY TO CHEMOTHERAPY AGENTS AS ASSESSED BY THE MTS ASSAY, Journal of leukocyte biology, 1998, pp. 10-10
Authors:
GIATROMANOLAKI A
KOUKOURAKIS MI
KAKOLYRIS S
KAKLAMANIS L
BARBATIS K
OBYRNE KJ
THEODOSSIOU D
HARRIS AL
GATTER KC
Citation: A. Giatromanolaki et al., FOCAL EXPRESSION OF THYMIDINE PHOSPHORYLASE ASSOCIATES WITH CD31 POSITIVE LYMPHOCYTIC AGGREGATION AND LOCAL NEO-ANGIOGENESIS IN NONSMALL CELL LUNG-CANCER, Anticancer research, 18(1A), 1998, pp. 71-76
Authors:
BLANCHER C
HARRIS AL
Citation: C. Blancher et Al. Harris, THE MOLECULAR-BASIS OF THE HYPOXIA RESPONSE PATHWAY - TUMOR HYPOXIA AS A THERAPY TARGET, Cancer metastasis reviews, 17(2), 1998, pp. 187-194
Authors:
HARRIS AL
Citation: Al. Harris, ARE ANGIOSTATIN AND ENDOSTATIN CURES FOR CANCER, Lancet, 351(9116), 1998, pp. 1598-1599
Authors:
TURLEY H
SCOTT PAE
WATTS VM
BICKNELL R
HARRIS AL
GATTER KC
Citation: H. Turley et al., EXPRESSION OF VEGF IN ROUTINELY FIXED MATERIAL USING A NEW MONOCLONAL-ANTIBODY VG1, Journal of pathology, 186(3), 1998, pp. 313-318
Authors:
ZHANG L
SCOTT PAE
TURLEY H
LEEK R
LEWIS CE
GATTER KC
HARRIS AL
MACKENZIE IZ
REES MCP
BICKNELL R
Citation: L. Zhang et al., VALIDATION OF ANTIVASCULAR ENDOTHELIAL GROWTH-FACTOR (ANTI-VEGF) ANTIBODIES FOR IMMUNOHISTOCHEMICAL LOCALIZATION OF VEGF IN TISSUE-SECTIONS- EXPRESSION OF VEGF IN THE HUMAN ENDOMETRIUM, Journal of pathology, 185(4), 1998, pp. 402-408
Authors:
GUDDO F
GIATROMANOLAKI A
KOUKOURAKIS MI
REINA C
VIGNOLA AM
CHLOUVERAKIS G
HILKENS J
GATTER KC
HARRIS AL
BONSIGNORE G
Citation: F. Guddo et al., MUC1 (EPISIALIN) EXPRESSION IN NONSMALL CELL LUNG-CANCER IS INDEPENDENT OF EGFR AND C-ERBB-2 EXPRESSION AND CORRELATES WITH POOR SURVIVAL IN NODE-POSITIVE PATIENTS, Journal of Clinical Pathology, 51(9), 1998, pp. 667-671
Authors:
KAGAN CR
HARRIS TD
HARRIS AL
SCHILLING ML
Citation: Cr. Kagan et al., SUBMICRON CONFOCAL RAMAN IMAGING OF HOLOGRAMS IN MULTICOMPONENT PHOTOPOLYMERS, The Journal of chemical physics, 108(16), 1998, pp. 6892-6896
Authors:
BEVANS CG
KORDEL M
RHEE SK
HARRIS AL
Citation: Cg. Bevans et al., ISOFORM COMPOSITION OF CONNEXIN CHANNELS DETERMINES SELECTIVITY AMONG2ND MESSENGERS AND UNCHARGED MOLECULES, The Journal of biological chemistry, 273(5), 1998, pp. 2808-2816
Authors:
SCOTT PAE
GLEADLE JM
BICKNELL R
HARRIS AL
Citation: Pae. Scott et al., ROLE OF THE HYPOXIA SENSING SYSTEM, ACIDITY AND REPRODUCTIVE HORMONESIN THE VARIABILITY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR INDUCTION INHUMAN BREAST-CARCINOMA CELL-LINES, International journal of cancer, 75(5), 1998, pp. 706-712
Authors:
SOPER NJ
HARRIS AL
STRACHAN RA
Citation: Nj. Soper et al., TECTONOSTRATIGRAPHY OF THE MOINE SUPERGROUP - A SYNTHESIS, Journal of the Geological Society, 155, 1998, pp. 13-24
Authors:
HARRIS AL
FETTES DJ
SOPER NJ
Citation: Al. Harris et al., AGE OF THE GRAMPIAN EVENT - A DISCUSSION OF NEW EVIDENCE THAT THE LOWER CAMBRIAN LENY LIMESTONE AT CALLANDER, PERTHSHIRE, BELONGS TO THE DALRADIAN SUPERGROUP, AND A REASSESSMENT OF THE EXOTIC STATUS OF THE HIGHLAND BORDER COMPLEX, Geological Magazine, 135(4), 1998, pp. 575-575
Authors:
PATTERSON AV
TALBOT DC
STRATFORD IJ
HARRIS AL
Citation: Av. Patterson et al., THYMIDINE PHOSPHORYLASE MODERATES THYMIDINE-DEPENDENT RESCUE AFTER EXPOSURE TO THE THYMIDYLATE SYNTHASE INHIBITOR ZD1694 (TOMUDEX) IN-VITRO, Cancer research, 58(13), 1998, pp. 2737-2740
Authors:
JONSSON M
SMITH K
HARRIS AL
Citation: M. Jonsson et al., REGULATION OF WNT5A EXPRESSION IN HUMAN MAMMARY CELLS BY PROTEIN-KINASE-C ACTIVITY AND THE CYTOSKELETON, British Journal of Cancer, 78(4), 1998, pp. 430-438
Authors:
PROPPER DJ
MACAULAY V
OBYRNE KJ
BRAYBROOKE JP
WILNER SM
GANESAN TS
TALBOT DC
HARRIS AL
Citation: Dj. Propper et al., A PHASE-II STUDY OF BRYOSTATIN-1 IN METASTATIC MALIGNANT-MELANOMA, British Journal of Cancer, 78(10), 1998, pp. 1337-1341
Authors:
LEVITTL NC
ESKENS F
PROPPER DJ
HARRIS AL
DENIS L
GANESAN TS
MATHER RA
MCKINLEY L
PLANTING A
TALBOT DC
VANBEURDEN V
VANDERBURG M
WILNER S
VERWEIJ J
Citation: Nc. Levittl et al., PHASE ONE PHARMACOKINETIC STUDY OF CGS27023A, A MATRIX METALLOPROTEINASE INHIBITOR, British Journal of Cancer, 78, 1998, pp. 23-23
Authors:
SAUNDERS MP
PATTERSON AV
RATCLIFFE PJ
HARRIS AL
STRATFORD IJ
Citation: Mp. Saunders et al., SELECTIVELY ACTIVATING BIOREDUCTIVE DRUGS IN-VITRO USING GENE-THERAPY, British Journal of Cancer, 78, 1998, pp. 47-47